Loading...
Derniers dépôts
-
Vida Terzić, Joe Miantezila Basilua, Nicolas Billard, Lucie de Gastines, Drifa Belhadi, et al.. Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19): A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial. Clinical Infectious Diseases, 2024, ⟨10.1093/cid/ciae170⟩. ⟨hal-04529469v2⟩
-
Xavier Vanhoye, Alexandre Janin, Amandine Caillaud, Antoine Rimbert, Fabienne Venet, et al.. APOB CRISPR-Cas9 Engineering in Hypobetalipoproteinemia: A Promising Tool for Functional Studies of Novel Variants. International Journal of Molecular Sciences, 2022, 23 (8), pp.4281. ⟨10.3390/ijms23084281⟩. ⟨hal-03659209⟩
-
Maya Hites, Clément Massonnaud, Eva Larranaga Lapique, Drifa Belhadi, Simon Jamard, et al.. Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial. Journal of Infection, 2024, 88 (3), pp.106120. ⟨10.1016/j.jinf.2024.106120⟩. ⟨hal-04577427⟩
-
Joséphine M. Reynaud, Jean-François Jégou, Jérémy C. Welsch, Branka Horvat. Human herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9. Journal of Virology, 2014, 88 (10), pp.5421-5436. ⟨10.1128/JVI.03763-13⟩. ⟨hal-01911356⟩
-
Anne-Sophie Godeux, Elin Svedholm, Samuel Barreto, Anaïs Potron, Samuel Venner, et al.. Erratum for Godeux et al., “Interbacterial Transfer of Carbapenem Resistance and Large Antibiotic Resistance Islands by Natural Transformation in Pathogenic Acinetobacter”. mBio, 2022, 13 (2), pp.e0052622. ⟨10.1128/mbio.00526-22⟩. ⟨hal-04225950⟩
-
Caroline Borciuch, Mathieu Fauvernier, Mathieu Gerfaud-Valentin, Pascal Sève, Yvan Jamilloux. Still’s Disease Mortality Trends in France, 1979–2016: A Multiple-Cause-of-Death Study. Journal of Clinical Medicine, 2021, Advances in Adult-Onset Still’s Disease and Systemic Juvenile Idiopathic Arthritis, 10 (19), pp.4544. ⟨10.3390/jcm10194544⟩. ⟨hal-04385910⟩
-
Camille Allam, William Mouton, Hugo Testaert, Christophe Ginevra, Noémie Fessy, et al.. Hyper-inflammatory profile and immunoparalysis in patients with severe Legionnaires’ disease. Frontiers in Cellular and Infection Microbiology, 2023, 13, pp.1252515. ⟨10.3389/fcimb.2023.1252515⟩. ⟨inserm-04668886⟩
Nombre de notices
1 213
Nombre de documents
1 148
Répartition par type de documents
Evolution
Dernières publications
-
Sandra Chyderiotis, Jonathan Sicsic, Amandine Gagneux-Brunon, Jocelyn Raude, Anne-Sophie Barret, et al.. Optimizing Communication on HPV Vaccination to Parents of 11- to 14-Year-Old Adolescents in France: A Discrete Choice Experiment. The Patient - Patient-Centered Outcomes Research, 2024, 17 (5), pp.575-588. ⟨10.1007/s40271-024-00687-6⟩. ⟨hal-04578136⟩
-
Jill-Léa Ramassamy, Ahidjo Ayouba, Guillaume Thaurignac, Chanceline Bilounga Ndongo, Patrick Nnuka, et al.. High seroreactivities to orthoebolaviruses in rural Cameroon: a case-control study on non-human primate bites and a cross-sectional survey in rural population. Journal of Infectious Diseases, 2024, pp.jiae399. ⟨10.1093/infdis/jiae399⟩. ⟨pasteur-04670559⟩
-
Christine Durier, Laetitia Ninove, Sylvie van der Werf, Maeva Lefebvre, Corinne Desaint, et al.. Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination. Infectious Diseases Now, 2024, 54 (5), pp.104886. ⟨10.1016/j.idnow.2024.104886⟩. ⟨hal-04596145⟩
-
Daniela Ogonczyk-Makowska, Pauline Brun, Clémence Vacher, Caroline Chupin, Clément Droillard, et al.. Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice. NPJ vaccines, 2024, 9 (1), pp.111. ⟨10.1038/s41541-024-00899-9⟩. ⟨hal-04633271⟩